Because of the recent focus of public attention on sickle cell disease and the other sickling hemoglobinopathies, the National Institutes of Health sponsored the first National Symposium on Sickle Cell Disease, held in Washington, DC, June 27 through 29, 1974. Each individual who submitted an abstract to this meeting, whether it was presented or not, was asked to write a 500 to 800-word summary, with references, of their contribution for the published proceedings. The book consists of 137 such summaries.
The summaries are divided into four sessions. The first contains those papers that were presented in the plenary session, emphasizing the pathogenesis of sickle cell disease. This session also deals with current proposed chemical treatment of sickle cell disease (zinc, cynate, and nitrogen and sulfur mustards). The next three sessions deal with the molecular, cellular, and clinical aspects of sickle cell disease, respectively.
In addition to the research summaries, there